This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Gadsby, R. Search for Related Content Social Bookmarking                   What's this?

Using insulin earlier in the treatment of type 2 diabetes

Centre for Primary Healthcare Studies, Warwick University, Coventry, CV4 7AL, UK, Roger.Gadsby{at}warwick.ac.uk

Type 2 diabetes is a progressive disease. Initial management with diet and exercise is fundamental. However, even if concordance is good, many will go on to require oral agent therapy to control hyperglycaemia. Initial metformin monotherapy and then oral combination therapy may be required as the disease progresses. When combinations of oral agents are insufficient to achieve good glycaemic control insulin therapy will be required. Various combinations of insulin and oral agents can be used to reduce the complications of hypoglycaemia and weight gain associated with insulin treatment. Simple regimes, using once-daily long-acting insulin analogues combined with oral metformin would seem to offer the possibility of good glycaemic control with minimal weight gain and hypoglycaemia.

Key Words: type 2 diabetes • oral agents • insulin • hypoglycaemia • basal insulin • glycaemic control.

The British Journal of Diabetes & Vascular Disease, Vol. 3, No. 2, 119-122 (2003)
DOI: 10.1177/14746514030030020701


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?